NDC codes

FDA NDC Directory
Product NDC (as listed)50090-5236Labeler and product segments. Claims need a package NDC.
Product NDC at billing width50090-5236Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
50090-5236-05009052360030 TABLET, FILM COATED in 1 BOTTLE (50090-5236-0)Marketed from Oct 9, 2020
50090-5236-15009052360190 TABLET, FILM COATED in 1 BOTTLE (50090-5236-1)Marketed from Oct 9, 2020

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Sildenafil
Generic name (nonproprietary)
sildenafil
Active ingredients
Sildenafil citrate — 20 mg/1
Dosage form
Tablet, Film coated
Route
Oral
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 203623
Marketing start
Listing expires
Other FDA classes
Phosphodiesterase 5 Inhibitors (Mechanism)
Identifiers
Product ID 50090-5236_eba51b78-3ceb-4350-9d17-cdd7b188e420SPL ID eba51b78-3ceb-4350-9d17-cdd7b188e420SPL set ID 34845de2-9b11-49c0-b684-cc8efb31386aRxCUI 577033UNII BW9B0ZE037
Pharmacologic class
Phosphodiesterase 5 Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N450090523600 followed by a unit qualifier and the quantity

Package 50090-5236-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

Adults Sildenafil tablets are indicated for the treatment of pulmonary arterial hypertension (PAH) (World Health Organization [WHO] Group I) in adults to improve exercise ability and delay clinical worsening [see Clinical Studies ( 14 )] . Pediatric Patients (1 to 17 Years old) Sildenafil tablets are indicated in pediatric patients 1 to 17 years old for the treatment of pulmonary arterial hypertension (PAH) (WHO Group I) to improve exercise ability and, in pediatric patients too young to perform standardized exercise testing, pulmonary hemodynamics thought to underly improvements in exercise [see Clinical Studies ( 14 )] . Adults Sildenafil tablets are a phosphodiesterase-5 (PDE-5) inhibitor…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 203623

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 203623
ProductStrengthForm · routeLabelerProduct NDC
SildenafilSildenafil citrate 20 mg/1Tablet, Film coatedOralNuCare Pharmaceuticals,Inc.68071-2213
SildenafilSildenafil citrate 20 mg/1Tablet, Film coatedOralCamber Pharmaceuticals, Inc.31722-776
SildenafilSildenafil citrate 20 mg/1Tablet, Film coatedOralXLCare Pharmaceuticals, Inc.72865-105
SildenafilSildenafil citrate 20 mg/1Tablet, Film coatedOralBryant Ranch Prepack71335-1649
SildenafilSildenafil citrate 20 mg/1Tablet, Film coatedOralBryant Ranch Prepack72162-2363
SildenafilSildenafil citrate 20 mg/1Tablet, Film coatedOralProficient Rx LP63187-619

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in